Advertisement

Hormone Therapy Soon After Menopause: New Findings Get Attention — Physician’s First Watch

Medical News |
October 5, 2012

Hormone Therapy Soon After Menopause: New Findings Get Attention

Patients may want to discuss widely reported findings about hormone therapy for early menopausal symptoms presented Wednesday evening at a North American Menopause Society meeting.

The Kronos Early Estrogen Prevention Study (KEEPS) randomized some 700 women within 3 years after menopause to 4 years' treatment with micronized progesterone (Prometrium) plus either oral conjugated equine estrogens (Premarin, 0.45 mg/day), transdermal estradiol (Climara patch, 50 μg/day), or placebo.

"The data showed improvements in cognition, mood, menopausal symptoms, and sexual function in younger women," Kronos Longevity Research Institute director S. Mitchell Harman said in a news release. "In addition, some measures showed slight evidence that hormone therapy might be cardio-protective in this age group, although results were not definitive and would require additional study."

The trials results have not yet been published.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement